Alzheimer's Disease Stocks List
Symbol | Grade | Name | % Change |
---|---|---|---|
ACAD | F | ACADIA Pharmaceuticals Inc. | -0.38 |
AGEN | F | Agenus Inc. | -1.12 |
BIIB | D | Biogen Idec Inc. | 1.75 |
IDRA | F | Idera Pharmaceuticals, Inc. | -4.42 |
LGND | D | Ligand Pharmaceuticals Incorporated | -1.42 |
NYMX | F | Nymox Pharmaceutical Corporation | -0.88 |
PRTA | B | Prothena Corporation plc | 7.05 |
SAVA | F | Cassava Sciences, Inc. | -1.63 |
NAVB | F | Navidea Biopharmaceuticals, Inc. | 0.00 |
NHC | C | National HealthCare Corporation | 1.32 |
OPK | F | OPKO Health Inc. | 2.73 |
PFE | B | Pfizer, Inc. | 1.16 |
ITCI | D | Intra-Cellular Therapies Inc. | 0.25 |
GLMD | F | Galmed Pharmaceuticals Ltd. | -3.64 |
ADMS | D | Adamas Pharmaceuticals, Inc. | 3.24 |
VTVT | C | vTv Therapeutics Inc. | -12.01 |
AVXL | D | Anavex Life Sciences Corp. | -5.83 |
AXSM | F | Axsome Therapeutics, Inc. | -1.77 |
YMTX | F | Yumanity Therapeutics, Inc. | 2.85 |
ACIU | D | AC Immune SA | 2.77 |
DNLI | D | Denali Therapeutics Inc. | 1.37 |
CRTX | D | Cortexyme, Inc. | 6.21 |
BLU | C | BELLUS Health Inc. | -2.23 |
ANVS | D | Annovis Bio, Inc. | -5.81 |
CYTH | F | Cyclo Therapeutics, Inc. | -2.68 |
Symbol | Grade | Name | Weight |
---|---|---|---|
DWSH | F | AdvisorShares Dorsey Wright Short ETF | 74.8 |
IHE | D | iShares U.S. Pharmaceutical ETF | 19.02 |
PJP | C | PowerShares Dynamic Pharmaceuticals | 11.63 |
XPH | D | SPDR S&P Pharmaceuticals ETF | 10.44 |
IEIH | D | iShares Evolved U.S. Innovative Healthcare ETF | 9.64 |
View all Alzheimer's Disease related ETFs...
Compare ETFs
Date | Stock | Signal | Type |
---|---|---|---|
2021-04-15 | ACAD | Narrow Range Bar | Range Contraction |
2021-04-15 | ACAD | 1,2,3 Retracement Bearish | Bearish Swing Setup |
2021-04-15 | ACAD | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-04-15 | ACIU | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-04-15 | ADMS | Crossed Above 20 DMA | Bullish |
2021-04-15 | ADMS | Pocket Pivot | Bullish Swing Setup |
2021-04-15 | ADMS | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-04-15 | ADMS | MACD Bullish Signal Line Cross | Bullish |
2021-04-15 | AVXL | Lower Bollinger Band Walk | Weakness |
2021-04-15 | AVXL | MACD Bearish Centerline Cross | Bearish |
2021-04-15 | BIIB | 20 DMA Resistance | Bearish |
2021-04-15 | BIIB | Crossed Above 200 DMA | Bullish |
2021-04-15 | BIIB | 50 DMA Resistance | Bearish |
2021-04-15 | BIIB | Stochastic Buy Signal | Bullish |
2021-04-15 | BLU | Cup with Handle | Other |
2021-04-15 | CRTX | Crossed Above 50 DMA | Bullish |
2021-04-15 | CYTH | Narrow Range Bar | Range Contraction |
2021-04-15 | CYTH | NR7 | Range Contraction |
2021-04-15 | DNLI | Shooting Star Candlestick | Bearish |
2021-04-15 | DNLI | Crossed Above 20 DMA | Bullish |
2021-04-15 | DNLI | NR7 | Range Contraction |
2021-04-15 | DNLI | Bollinger Band Squeeze | Range Contraction |
2021-04-15 | DNLI | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-04-15 | GLMD | MACD Bearish Signal Line Cross | Bearish |
2021-04-15 | IDRA | New 52 Week Low | Weakness |
2021-04-15 | IDRA | Narrow Range Bar | Range Contraction |
2021-04-15 | IDRA | New 52 Week Closing Low | Bearish |
2021-04-15 | ITCI | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-04-15 | ITCI | Doji - Bearish? | Reversal |
2021-04-15 | ITCI | Shooting Star Candlestick | Bearish |
2021-04-15 | ITCI | 20 DMA Resistance | Bearish |
2021-04-15 | ITCI | MACD Bullish Signal Line Cross | Bullish |
2021-04-15 | LGND | 20 DMA Resistance | Bearish |
2021-04-15 | NAVB | NR7 | Range Contraction |
2021-04-15 | NAVB | Narrow Range Bar | Range Contraction |
2021-04-15 | NYMX | MACD Bullish Signal Line Cross | Bullish |
2021-04-15 | NYMX | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-04-15 | OPK | 200 DMA Resistance | Bearish |
2021-04-15 | OPK | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup |
2021-04-15 | OPK | 20 DMA Resistance | Bearish |
2021-04-15 | PFE | Pocket Pivot | Bullish Swing Setup |
2021-04-15 | PFE | Upper Bollinger Band Walk | Strength |
2021-04-15 | PRTA | Crossed Above 20 DMA | Bullish |
2021-04-15 | SAVA | Narrow Range Bar | Range Contraction |
2021-04-15 | SAVA | Stochastic Buy Signal | Bullish |
2021-04-15 | VTVT | Upper Bollinger Band Walk | Strength |
2021-04-15 | YMTX | Stochastic Reached Oversold | Weakness |
2021-04-15 | YMTX | NR7-2 | Range Contraction |
2021-04-15 | YMTX | NR7 | Range Contraction |
2021-04-15 | YMTX | Narrow Range Bar | Range Contraction |
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the typical life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD; however, evidence to support these recommendations is not strong. There are no medications or supplements that have been shown to decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programmes may be beneficial with respect to activities of daily living and can potentially improve outcomes. Behavioural problems or psychosis due to dementia are often treated with antipsychotics, but this is not usually recommended, as there is little benefit with an increased risk of early death.In 2015, there were approximately 29.8 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2015, dementia resulted in about 1.9 million deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.
Mike's Notes
- CHWY: One of my fa...
- TWLO: Here's anoth...
- ABNB: An interesti...
- CGNT: Not a chart ...
- TDOC: One of sever...
From the Blog
Popular Now
Featured Articles
- Can you just follow your plan already?
- Rallies in downtrends aren’t times to jump back in
- What You Trade Is As Important As How You Trade
- Breakouts, Home Runs & Exponential Returns w/ Kristjan Kullamägi
- Tech Stock Indices: Do Bulls Have A Problem?
- Semi-automating Your Trading
- Recommended Stock Trading Books